Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study)

American Journal of Cardiology

Volumn 118, Issue 6, 2016, Pages 816-821

  Lyngbakken, Magnus Nakrem ^a,b   Røsjø, Helge ^a,b   Holmen, Oddgeir L ^c   Nygård, Ståle ^d   Dalen, Håvard ^c,e   Hveem, Kristian ^c   Omland, Torbjørn ^a,b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e North Trondelag Hospital Trust   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORWAY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; BLOOD; INCIDENCE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL;

ADULT; BIOMARKERS; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS; TROPONIN I;

EID: 84995483159     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.06.043     Document Type: Article

References (30)

1. 1 Towfighi, A., Zheng, L., Ovbiagele, B., Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 169 (2009), 1762–1766.
2. 2 Doumas, M., Papademetriou, V., Faselis, C., Kokkinos, P., Gender differences in hypertension: myths and reality. Curr Hypertens Rep 15 (2013), 321–330.
3. 3 Corrao, M.A., Guindon, G.E., Cokkinides, V., Sharma, N., Building the evidence base for global tobacco control. Bull World Health Organ 78 (2000), 884–890.
4. 4 Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., Thygesen, K., Alpert, J.S., White, H.D., Jaffe, A.S., Katus, H.A., Apple, F.S., Lindahl, B., Morrow, D.A., Chaitman, B.A., Clemmensen, P.M., Johanson, P., Hod, H., Underwood, R., Bax, J.J., Bonow, R.O., Pinto, F., Gibbons, R.J., Fox, K.A., Atar, D., Newby, L.K., Galvani, M., Hamm, C.W., Uretsky, B.F., Steg, P.G., Wijns, W., Bassand, J.P., Menasche, P., Ravkilde, J., Ohman, E.M., Antman, E.M., Wallentin, L.C., Armstrong, P.W., Simoons, M.L., Januzzi, J.L., Nieminen, M.S., Gheorghiade, M., Filippatos, G., Luepker, R.V., Fortmann, S.P., Rosamond, W.D., Levy, D., Wood, D., Smith, S.C., Hu, D., Lopez-Sendon, J.L., Robertson, R.M., Weaver, D., Tendera, M., Bove, A.A., Parkhomenko, A.N., Vasilieva, E.J., Mendis, S., Third universal definition of myocardial infarction. Eur Heart J 33 (2012), 2551–2567.
5. 5 de Lemos, J.A., Drazner, M.H., Omland, T., Ayers, C.R., Khera, A., Rohatgi, A., Hashim, I., Berry, J.D., Das, S.R., Morrow, D.A., McGuire, D.K., Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304 (2010), 2503–2512.
6. 6 Zeller, T., Ojeda, F., Brunner, F.J., Peitsmeyer, P., Munzel, T., Binder, H., Pfeiffer, N., Michal, M., Wild, P.S., Blankenberg, S., Lackner, K.J., High-sensitivity cardiac troponin I in the general population—defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 53 (2015), 699–706.
7. 7 Omland, T., de Lemos, J.A., Sabatine, M.S., Christophi, C.A., Rice, M.M., Jablonski, K.A., Tjora, S., Domanski, M.J., Gersh, B.J., Rouleau, J.L., Pfeffer, M.A., Braunwald, E., Prevention of Events With Angiotensin Converting Enzyme Inhibition Trial I. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361 (2009), 2538–2547.
8. 8 Saunders, J.T., Nambi, V., de Lemos, J.A., Chambless, L.E., Virani, S.S., Boerwinkle, E., Hoogeveen, R.C., Liu, X., Astor, B.C., Mosley, T.H., Folsom, A.R., Heiss, G., Coresh, J., Ballantyne, C.M., Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123 (2011), 1367–1376.
9. 9 Zeller, T., Tunstall-Pedoe, H., Saarela, O., Ojeda, F., Schnabel, R.B., Tuovinen, T., Woodward, M., Struthers, A., Hughes, M., Kee, F., Salomaa, V., Kuulasmaa, K., Blankenberg, S., Investigators, M., High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 35 (2014), 271–281.
10. 10 Omland, T., Pfeffer, M.A., Solomon, S.D., de Lemos, J.A., Rosjo, H., Saltyte Benth, J., Maggioni, A., Domanski, M.J., Rouleau, J.L., Sabatine, M.S., Braunwald, E., Investigators, P., Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 61 (2013), 1240–1249.
11. 11 Omland, T., de Lemos, J.A., Holmen, O.L., Dalen, H., Benth, J.S., Nygard, S., Hveem, K., Rosjo, H., Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem 61 (2015), 646–656.
12. 12 Krokstad, S., Langhammer, A., Hveem, K., Holmen, T.L., Midthjell, K., Stene, T.R., Bratberg, G., Heggland, J., Holmen, J., Cohort profile: the HUNT study, Norway. Int J Epidemiol 42 (2013), 968–977.
13. 13 Laugsand, L.E., Strand, L.B., Platou, C., Vatten, L.J., Janszky, I., Insomnia and the risk of incident heart failure: a population study. Eur Heart J 35 (2014), 1382–1393.
14. 14 Everett, B.M., Cook, N.R., Magnone, M.C., Bobadilla, M., Kim, E., Rifai, N., Ridker, P.M., Pradhan, A.D., Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 123 (2011), 2811–2818.
15. 15 Gore, M.O., Seliger, S.L., Defilippi, C.R., Nambi, V., Christenson, R.H., Hashim, I.A., Hoogeveen, R.C., Ayers, C.R., Sun, W., McGuire, D.K., Ballantyne, C.M., de Lemos, J.A., Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 63 (2014), 1441–1448.
16. 16 Apple, F.S., Ler, R., Murakami, M.M., Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58 (2012), 1574–1581.
17. 17 Apple, F.S., Collinson, P.O., Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 58 (2012), 54–61.
18. 18 White, H.D., Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J Am Coll Cardiol 57 (2011), 2406–2408.
19. 19 Mosca, L., Benjamin, E.J., Berra, K., Bezanson, J.L., Dolor, R.J., Lloyd-Jones, D.M., Newby, L.K., Pina, I.L., Roger, V.L., Shaw, L.J., Zhao, D., Beckie, T.M., Bushnell, C., D'Armiento, J., Kris-Etherton, P.M., Fang, J., Ganiats, T.G., Gomes, A.S., Gracia, C.R., Haan, C.K., Jackson, E.A., Judelson, D.R., Kelepouris, E., Lavie, C.J., Moore, A., Nussmeier, N.A., Ofili, E., Oparil, S., Ouyang, P., Pinn, V.W., Sherif, K., Smith, S.C. Jr., Sopko, G., Chandra-Strobos, N., Urbina, E.M., Vaccarino, V., Wenger, N.K., Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation 123 (2011), 1243–1262.
20. 20 Lerner, D.J., Kannel, W.B., Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111 (1986), 383–390.
21. 21 Eng, J., McClelland, R.L., Gomes, A.S., Hundley, W.G., Cheng, S., Wu, C.O., Carr, J.J., Shea, S., Bluemke, D.A., Lima, J.A., Adverse left ventricular remodeling and age assessed with cardiac MR imaging: the Multi-Ethnic Study of Atherosclerosis. Radiology 278 (2015), 714–722.
22. 22 Barrett-Connor, E., Sex differences in coronary heart disease: why are women so superior? the 1995 Ancel Keys Lecture. Circulation 95 (1997), 252–264.
23. 23 Lloyd-Jones, D.M., Wilson, P.W., Larson, M.G., Beiser, A., Leip, E.P., D'Agostino, R.B., Levy, D., Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 94 (2004), 20–24.
24. 24 Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Matchar, D.B., McGuire, D.K., Mohler, E.R. III, Moy, C.S., Muntner, P., Mussolino, M.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Willey, J.Z., Woo, D., Yeh, R.W., Turner, M.B., Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–e322.
25. 25 Ahmad, T., Pencina, M.J., Schulte, P.J., O'Brien, E., Whellan, D.J., Pina, I.L., Kitzman, D.W., Lee, K.L., O'Connor, C.M., Felker, G.M., Clinical implications of chronic heart failure phenotypes defined by cluster analysis. J Am Coll Cardiol 64 (2014), 1765–1774.
26. 26 Lee, D.S., Gona, P., Vasan, R.S., Larson, M.G., Benjamin, E.J., Wang, T.J., Tu, J.V., Levy, D., Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 119 (2009), 3070–3077.
27. 27 Ather, S., Chan, W., Bozkurt, B., Aguilar, D., Ramasubbu, K., Zachariah, A.A., Wehrens, X.H., Deswal, A., Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59 (2012), 998–1005.
28. 28 Bentzon, J.F., Otsuka, F., Virmani, R., Falk, E., Mechanisms of plaque formation and rupture. Circ Res 114 (2014), 1852–1866.
29. 29 Heusch, G., Kleinbongard, P., Böse, D., Levkau, B., Haude, M., Schulz, R., Erbel, R., Coronary microembolization: from bedside to bench and back to bedside. Circulation 120 (2009), 1822–1836.
30. 30 Moreno, V., Hernandez-Romero, D., Vilchez, J.A., Garcia-Honrubia, A., Cambronero, F., Casas, T., Gonzalez, J., Martinez, P., Climent, V., de la Morena, G., Valdes, M., Marin, F., Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail 16 (2010), 950–956.